American Journal on Addictions

Article	Citations
Issue Information	29
Stand against stigma	26
AAAP's Annual Meeting and Scientific Symposium	26
Self assessment ad (002)	23
AAAP 36th Annual Meeting & Scientific Symposium Save the Date	22
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada	20
Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment‐seeking cohort	16
Availability of substance use disorder treatment in Spanish: Associations with state‐level proportions of Spanish speakers and treatment facility characteristics in the United States	15
2024 Annual Meeting Posters	15
Call for Special Issue 2024	15
AAAP Stimulant Use Disorder PIP	14
A scoping review of sensory‐based interventions to address alcohol consumption	13
Gender differences in circumstances associated with cannabis use	13
Barriers for recruitment to treatment of youths with co‐occurring substance use disorders and depression	13
Time spent on social media and depressive symptoms in university students: The mediating role of psychoactive substances	12
Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment	12
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey	12
Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–2021	12
AAAP Annual meeting ad	11
Issue Information	11
Call for Special Issue Papers 2025	11
Call for Review Papers 2024	10
Correlates of optimism among patients in substance use disorder inpatient treatment	10
Become a member of AAAP!	10
AM Registration Flyer	10

Tobacco use and impulsivity in people with mental illness: A systematic review	10
Call for Special Issue Papers 2024	9
Synthetic cannabinoid use and the acquired preparedness model	9
Emotional regulation in Gaming Disorder: A systematic review	9
Call for Review Papers 2024	9
Neurodevelopmental burden in young adults undergoing opioid substitution therapy: The role of inattentive and hyperactive/impulsive symptoms	9
Identifying factors associated with peer recovery coach interactions and successful outcomes for patients with opioid use disorder in Southern West Virginia	9
Narcotics Anonymous members in recovery from methamphetamine use disorder	9
Patient–provider interactions about cannabis for therapeutic purposes vary as a function of provider type: A pilot study	8
Exploring cannabis as a treatment for chronic pain in a rural Appalachian population	8
Does cyber dating abuse victimization predict next‐day alcohol and cannabis use among college students?	8
	8
An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications	7
Call for review papers 2022	7
Preconference On‐Demand availability	7
Marijuana use disorder among adults with functional disabilities—A US population‐based cross‐sectional study	7
Issue Information ‐ Editorial Board	7
Issue Information ‐ Editorial Board	7
Extended‐release buprenorphine in pregnancy	7
Issue Information ‐ ToC	7
AAAP AATT Preconference	6
AAAP Podcast EP	6
Posttraumatic stress disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical correlates	6
AAAP Call for Abstracts	6
AJA Annual Meeting 2023	6
Issue Information	6
Issue Information ‐ Editorial Board	5
2023 Advanced Addiction Psychopharmacology Course	5
AAAP's Performance in practice activities	5
Personality predicting relapse: A facet analysis of the NEO PI‐R	5
Stand Against Stigma	5
Differences in intent to refer buprenorphine among community correctional and treatment staff: A set of cross‐lagged models predicting efficacy beliefs and familiarity with buprenorphine for opioid us	5
FREE Live Webinar Psychotherapy Series: CAMS Approach to Suicidal Risk ‐ David A. Jobes, PhD, ABPP (Aug 13, 2025)	5
Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs	5
Call for Review Papers 2025	5
BREAKING NEWS: AAAP Earns a Spot in ACCME's Innovation Partner Circle!	5
Issue Information ‐ ToC	5
Effects of persistent cannabis use on depression, psychosis, and suicidality following cannabis‐induced psychosis: A longitudinal study	5
Addiction specialists' attitudes toward psychedelics: A National Survey	4
Call for Special Issue Papers 2025	4
Call for Symposium Abstracts	4
2021 AJA Reviewer List	4
2023 Addictions and Their Treatment Course	4
Brief report: The influence of childhood trauma on the effects of delta‐9‐tetrahydrocannabinol in persons with opioid use disorder	4
Call for special issue 2023	4
Cannabis Use Disorders Performance in Practice	4
AAAP NEWSLETTER: What do your colleagues have to say about the latest updates in Addiction Psychiatry?	4
	4
State‐level racial and ethnic disparities in buprenorphine treatment duration in the United States	4
Health care service utilization and drug overdose death: A national nested case–control registry study	4

A systematic review and meta‐analysis of the relationship between heavy smoking and probability discounting	4
AJA AM Save the Date 2023	4
Call for Special Issue 2023	4
	3
AJA AM save the date 2023	3
AAAP Podcast Episode 10: A Discussion On Cybersecurity With Norma Krayem	3
Gambling, tobacco use, and health among individuals in substance use disorder treatment	3
The relationship between depressed affect, parental monitoring, and sex on cannabis use among American Indian youth	3
Issue Information ‐ Editorial Board	3
Mini‐Symposia I	3
AAAP 2024 Self‐Assessment Exam Now Available	3
Anxiety sensitivity and cannabis use motives among trauma‐exposed young adult cannabis users	3
AAAP Membership benefits	3
Stand Against Stigma	3
Save the Date ‐ Annual Meeting 2025	3
Sociodemographic profile and clinical presentation of young children unintentionally exposed to marijuana: A single site retrospective cohort	3
Medical Update	3
AAAP Advanced Addiction Psychopharmacology Virtual Course, October 5‐6, 2024	2
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID‐19 pandemic	2
Management of xylazine toxicity, overdose, dependence, and withdrawal: A systematic review	2
Call for special issue 2023	2
2025 Call for Symposium Abstracts	2
Concurrent Paper Sessions	2
Trends in substance use disorder diagnoses among Veterans, 2009–2019	2
Become an AAAP Member	2
AAAP Podcast Series, Episode 10: Discussion on Cybersecurity with Norma Krayem	2
Educating the community about the opioid epidemic and medications for opioid use disorder	2
Obsessive‐compulsive disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical characteristics	2
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo‐controlled crossover laboratory study	2
The mediating role of impulsivity in the relationship between childhood maltreatment and depression in methamphetamine patients	2
Daily cannabis use may cause cannabis‐induced hyperalgesia	2
Paper sessions	2
Brief Report: Expectancies for alcohol analgesia are associated with greater alcohol use among moderate‐to‐heavy drinkers without chronic pain	2
Addiction Psychiatry Advanced Psychotherapy Curriculum	2
Severe gamma‐hydroxybutyrate withdrawal with delirium, hemodynamic lability, and rhabdomyolysis: A case series	2
Issue Information ‐ Editorial Board	2
AAAP Membership	2
ORN Advancing racial equity	2
Opioid Recover Network ‐ ORN: Recruiting qualified consultants for the ORN	2
Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients	2
Medication Management for Stimulant Use Disorder Webinar	2
Call for Review Papers 2023	2
FREE WEBINAR: Master MI Techniques with Dr. Brian Borsari, September 10, 2025	2
Psychotherapy Webinar Series AJA	2
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders	2
Cannabis Use PIP Ad	2
Medical Update	1
Issue Information	1
Opioid overdose prevention and response training for medical students: Does training provide a benefit beyond the traditional curriculum, and are the gains of early training maintained?	1
AJA Annual Meeting 2024	1
Associations between alcohol and cannabis use order, frequency, quantity, and consequences in a college sample of individuals who co‐use alcohol and cannabis	1
Conference Schedule	1
Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting	1
Opioid use disorder in the active service: Implications for intervention	1
2023 Advanced Addiction Psychopharmacology Course	1
2024 Annual Meeting Posters	1
PCSS exchange AJA Ad	1
Understanding the role of cannabis use on cigarette dependence severity among individuals with e‐cigarette and combustible tobacco dual use	1
Are x‐waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x‐waiver trainings	1
Systematic review: Wearable remote monitoring to detect nonalcohol/nonnicotine‐related substance use disorder symptoms	1
Program title youth substance use and addiction timely updates on a critical issue	1
Addiction Psychiatry Advanced Psychotherapy Curriculum	1
AAAP ORN PIP ad	1
Alcohol use and alcohol‐related consequences based on gender and sexual orientation among college students	1
Examining family member characteristics by treatment status of the relative with substance use problems	1
Cannabis involvement in posttraumatic stress disorder emergency department visits after cannabis legalization	1
Cannabis and the overdose crisis among US adolescents	1
Feasibility and preliminary efficacy of a community support intervention for people with opioid use disorder	1
Legalization of cannabis in Canada—Local media analysis	1
Call for review papers 2022	1
Issue Information	1
Symposium I	1
Symposium III	1
Promoter region variant C‐824T in the TH gene modulates the subjective effects of cocaine	1
AAAP Pre‐Conference On‐Demand Course ‐ AATT & AAP	1
33rd AAAP Annual Meeting and Scientific Symposium Recap	1
Evaluating the substance use disorder treatment gap in the United States, 2016−2019: A population health observational study	1
32nd AAAP Annual meeting & scientific symposium recap	1
Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex	1
AJA Psychedelics	1

Treatment patterns and healthcare resource use among veterans initiating medication for incident moderate‐to‐severe alcohol use disorder	1
Call for special issue 2023	1
Mini‐Symposia II	1
Film & Media Workshop	1
Call for special issue 2023	1
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center	1
Issue Information ‐ ToC	1
AAAP conference agenda	1